loadpatents
name:-0.04419994354248
name:-0.026643037796021
name:-0.0049378871917725
BLONDINO; Frank E. Patent Filings

BLONDINO; Frank E.

Patent Applications and Registrations

Patent applications and USPTO patent grants for BLONDINO; Frank E..The latest application filed is for "devices and methods for delivering a lyophilized medicament".

Company Profile
3.21.31
  • BLONDINO; Frank E. - Henrico VA
  • Blondino; Frank E. - Easton PA
  • Blondino; Frank E. - Richmond VA
  • Blondino, Frank E. - Plantation FL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Devices And Methods For Delivering A Lyophilized Medicament
App 20200316299 - BLONDINO; Frank E. ;   et al.
2020-10-08
Devices and methods for delivering a lyophilized medicament
Grant 10,695,495 - Blondino , et al.
2020-06-30
Medicament Delivery Device For Administration Of Opioid Antagonists Including Formulations For Naloxone
App 20190290855 - EDWARDS; Eric S. ;   et al.
2019-09-26
Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Grant 10,322,239 - Edwards , et al.
2019-06-18
Devices And Methods For Delivering Medicaments From A Multi-chamber Container
App 20190151548 - EDWARDS; Eric S. ;   et al.
2019-05-23
Devices and methods for delivering medicaments from a multi-chamber container
Grant 10,226,583 - Edwards , et al.
2019-03-12
Devices and methods for delivering opioid antagonists including formulations for naloxone
Grant 10,220,158 - Blondino , et al.
2019-03-05
Medicament Delivery Device For Administration Of Opioid Antagonists Including Formulations For Naloxone
App 20190060557 - EDWARDS; Eric S. ;   et al.
2019-02-28
Devices and methods for delivering medicaments from a multi-chamber container
Grant 10,183,116 - Edwards , et al. Ja
2019-01-22
Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Grant 10,143,792 - Edwards , et al. De
2018-12-04
Devices And Methods For Delivering A Lyophilized Medicament
App 20180304018 - BLONDINO; Frank E. ;   et al.
2018-10-25
Medicament Delivery Device For Administration Of Opioid Antagonists Including Formulations For Naloxone
App 20180126082 - EDWARDS; Eric S. ;   et al.
2018-05-10
Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Grant 9,814,838 - Edwards , et al. November 14, 2
2017-11-14
Devices And Methods For Delivering Opioid Antagonists Including Formulations For Naloxone
App 20170232206 - BLONDINO; Frank E. ;   et al.
2017-08-17
Devices And Methods For Delivering Medicaments From A Multi-chamber Container
App 20170151393 - EDWARDS; Eric S. ;   et al.
2017-06-01
Medicament Delivery Device For Administration Of Opioid Antagonists Including Formulations For Naloxone
App 20170035957 - EDWARDS; Eric S. ;   et al.
2017-02-09
Devices and methods for delivering medicaments from a multi-chamber container
Grant 9,522,235 - Edwards , et al. December 20, 2
2016-12-20
Devices and methods for delivering opioid antagonists including formulations for naloxone
Grant 9,517,307 - Blondino , et al. December 13, 2
2016-12-13
Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Grant 9,474,869 - Edwards , et al. October 25, 2
2016-10-25
Devices And Methods For Delivering Medicaments From A Multi-chamber Container
App 20160184521 - EDWARDS; Eric S. ;   et al.
2016-06-30
Devices And Methods For Delivering Opioid Antagonists Including Formulations For Naloxone
App 20160015895 - Blondino; Frank E. ;   et al.
2016-01-21
Devices and methods for delivering medicaments from a multi-chamber container
Grant 9,173,999 - Edwards , et al. November 3, 2
2015-11-03
Medicament Delivery Device For Administration Of Opioid Antagonists Including Formulations For Naloxone
App 20150297840 - EDWARDS; Eric S. ;   et al.
2015-10-22
Medicament Delivery Device For Administration Of Opioid Antagonists Including Formulations For Naloxone
App 20150231336 - EDWARDS; Eric S. ;   et al.
2015-08-20
Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Grant 9,022,022 - Edwards , et al. May 5, 2
2015-05-05
Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Grant 8,939,943 - Edwards , et al. January 27, 2
2015-01-27
Medicament Delivery Device For Administration Of Opioid Antagonists Including Formulations For Naloxone
App 20140123974 - EDWARDS; Eric S. ;   et al.
2014-05-08
Medicament Delivery Device For Administration Of Opioid Antagonists Including Formulations For Naloxone
App 20140052069 - EDWARDS; Eric S. ;   et al.
2014-02-20
Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Grant 8,627,816 - Edwards , et al. January 14, 2
2014-01-14
Devices And Methods For Delivering Medicaments From A Multi-chamber Container
App 20130317477 - EDWARDS; Eric S. ;   et al.
2013-11-28
Devices And Methods For Delivering Medicaments From A Multi-chamber Container
App 20130023822 - Edwards; Eric S. ;   et al.
2013-01-24
Medicament Delivery Device For Administration Of Opioid Antagonists Including Formulations For Naloxone
App 20120217184 - Edwards; Eric S. ;   et al.
2012-08-30
Stable Hydroalcoholic Oral Spray Formulations And Methods
App 20110280916 - Blondino; Frank E. ;   et al.
2011-11-17
Stable Anti-nausea Oral Spray Formulations And Methods
App 20110171273 - Blondino; Frank E. ;   et al.
2011-07-14
Anti-insomnia Compositions And Methods
App 20110040266 - Blondino; Frank E. ;   et al.
2011-02-17
Aerosol formulations and aerosol delivery of buprenorphine
Grant 7,501,113 - Blondino , et al. March 10, 2
2009-03-10
Anti-insomnia Compositions And Methods
App 20080280947 - Blondino; Frank E. ;   et al.
2008-11-13
Aerosol formulations and aerosol delivery of scopolamine
Grant 7,410,635 - Blondino , et al. August 12, 2
2008-08-12
Stable anti-nausea oral spray formulations and methods
App 20080171089 - Blondino; Frank E. ;   et al.
2008-07-17
Anti-migraine Oral Spray Formulations And Methods
App 20080031959 - Blondino; Frank E. ;   et al.
2008-02-07
Stable Hydroalcoholic Oral Spray Formulations And Methods
App 20070248548 - Blondino; Frank E. ;   et al.
2007-10-25
Aerosol formulations and aerosol delivery of butalbital, lorazepam, ipratropium, baclofen, morphine and scopolamine
App 20050079137 - Blondino, Frank E. ;   et al.
2005-04-14
Aerosol formulations and aerosol delivery of buspirone, buprenorphine, triazolam, cyclobenzaprine and zolpidem
App 20040151670 - Blondino, Frank E. ;   et al.
2004-08-05
Pressurized metered dose inhalers and pharmaceutical aerosol fomulations
App 20030077230 - Blondino, Frank E. ;   et al.
2003-04-24
Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
Grant 6,451,285 - Blondino , et al. September 17, 2
2002-09-17
Pharmaceutical aerosol formulations containing fluoroalkanes and budesonide
App 20020127185 - Blondino, Frank E. ;   et al.
2002-09-12
Pressurized Metered Dose Inhalers And Pharmaceutical Aerosol Formulations
App 20020018753 - BLONDINO, FRANK E. ;   et al.
2002-02-14
Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
Grant 6,004,537 - Blondino , et al. December 21, 1
1999-12-21
Metered dose inhaler fomulations which include the ozone-friendly propellant HFC 134a and a pharmaceutically acceptable suspending, solubilizing, wetting, emulsifying or lubricating agent
Grant 5,492,688 - Byron , et al. February 20, 1
1996-02-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed